Log in to save to my catalogue

Brachytherapy: Increased Use in Patients With Intermediate- and High-Risk Prostate Cancers

Brachytherapy: Increased Use in Patients With Intermediate- and High-Risk Prostate Cancers

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_gale_infotracmisc_A663711312

Brachytherapy: Increased Use in Patients With Intermediate- and High-Risk Prostate Cancers

About this item

Full title

Brachytherapy: Increased Use in Patients With Intermediate- and High-Risk Prostate Cancers

Author / Creator

Publisher

United States: Oncology Nursing Society

Journal title

Clinical journal of oncology nursing, 2021-06, Vol.25 (3), p.321-328

Language

English

Formats

Publication information

Publisher

United States: Oncology Nursing Society

More information

Scope and Contents

Contents

Brachytherapy is a well-established and effective primary treatment modality for low- and favorable intermediate-risk prostate cancers. Although the benefits of brachytherapy in unfavorable intermediate- and high-risk prostate cancers have not been as clear, research suggests that brachytherapy boost may improve biochemical progression-free surviva...

Alternative Titles

Full title

Brachytherapy: Increased Use in Patients With Intermediate- and High-Risk Prostate Cancers

Authors, Artists and Contributors

Author / Creator

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_gale_infotracmisc_A663711312

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_gale_infotracmisc_A663711312

Other Identifiers

ISSN

1092-1095

E-ISSN

1538-067X

DOI

10.1188/21.CJON.321-328

How to access this item